KRTX Karuna Therapeutics Inc

About KRTX

Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological and psychiatric illnesses, with a particular focus on schizophrenia and the behavioral symptoms of Alzheimer's disease. The company is skilled in neuroscience and has creative ideas for finding and developing new drugs. Karuna Therapeutics isÂ advancing a pipeline of innovative drugs since its inception with the aim of significantly improving the lives of people suffering from these difficult conditions.

Neutral Sentiment

How do you feel about KRTX?

TechnoFunctional

Sep 23

My rationale is that such big ticket deals don't remain hidden and that will reflect in the price action. Example: $KRTX (Karuna Therapeutics), which was acquired for $14B by BMS in late 2023 at $330/share. In early Oct, it dipped to $158 but then gradually recovered to ~$220 before its BO annoucnement at ~50% premium. I find it highly improbable that a $15B+ deal will be signed at around 100% premium to prevaling stock price. There will be "informed" trading days/weeks before the deal is signed.